Understanding how gene silencing is controlled during development
Developmental control of gene silencing
['FUNDING_OTHER'] · MONTANA STATE UNIVERSITY - BOZEMAN · NIH-10933415
This study is looking at how certain proteins help turn off genes in cells, which is important for cells to become specialized, and it's designed for anyone interested in understanding how these processes might relate to developmental disorders and cancers.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | MONTANA STATE UNIVERSITY - BOZEMAN (nih funded) |
| Locations | 1 site (BOZEMAN, UNITED STATES) |
| Trial ID | NIH-10933415 on ClinicalTrials.gov |
What this research studies
This research investigates the role of Polycomb-group proteins in gene silencing, which is crucial for cell specialization. By using a model system involving Drosophila nurse cell differentiation, the study aims to uncover how these proteins regulate the initiation, maintenance, and reversal of gene silencing during development. The researchers will employ advanced genetic and genomic engineering tools, including a novel method called UAS-gene swap, to explore the interactions between these proteins and their target genes. This approach allows for a detailed examination of gene expression changes that could lead to developmental disorders and cancers.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals affected by developmental disorders or cancers linked to gene regulation issues.
Not a fit: Patients with conditions unrelated to gene silencing or those not affected by developmental disorders or cancers may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new insights into the mechanisms of gene regulation, potentially informing treatments for developmental disorders and certain cancers.
How similar studies have performed: While the specific approach of using Drosophila for this type of gene silencing research is innovative, similar studies have shown promise in understanding gene regulation mechanisms.
Where this research is happening
BOZEMAN, UNITED STATES
- MONTANA STATE UNIVERSITY - BOZEMAN — BOZEMAN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: DELUCA, STEVEN — MONTANA STATE UNIVERSITY - BOZEMAN
- Study coordinator: DELUCA, STEVEN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancers